Oocyte-specific gene mutations cause premature ovarian failure

“We hope to use the information from this study and others that identify genes associated with this problem to find biomarkers in blood that can help us determine a woman’s risk of early infertility,” said Dr. Aleksandar Rajkovic, associate professor of obstetrics and gynecology at BCM and senior author of the paper. Premature ovarian failure, which means that the ovaries lose function before age 40, not only causes infertility but also bone and heart problems, he said.

“It affects 1 percent of women,” he said. “While most people associate it with infertility, women with premature ovarian failure face an increased risk of cardiovascular disease, osteoporosis and premature death. Ovarian reserves are important for women’s health.”

In looking for genes that cause the disorder, Rajkovic and his colleagues here and in China concentrated on those that are most likely to function in the ovary. A gene mutation does not totally halt gene activity, but Rajkovic believes it can accelerate the loss of eggs (or germ cells). When all the eggs are lost, the ovaries stop producing estrogen, leading to menopause symptoms.

In this study, Rajkovic and his collaborators screened 100 Chinese women with premature ovarian failure for mutations in FIGLA and found three different kinds of mutations in the FIGLA genes of four.

FIGLA is one of four transcription factors found to control the differentiation of egg cells early in development. Transcription factors govern the activity of genes, turning them off and on and modulating the extent to which they are active.

The other genes involved include NOBOX, GDF9 and BMP 15, said Rajkovic. Mutations in these can lead to premature ovarian failure as well, he said.

“We hope to define majority of the genes that are part of the cellular pathways involved in ovarian failure,” said Rajkovic. “Ideally in the future we will offer a test to women to look at all the genes involved in premature ovarian failure.”

He anticipates that a gene chip would be helpful in such diagnosis, which can help in counseling women or their children about the risk of early ovarian failure.

Source: Baylor College of Medicine

New research provides insight into menopause
Insight into why females of some species undergo menopause while others do not has proven elusive despite an understanding of the biological mechanisms behind the change.
Variation of normal protein could be key to resistance to common cancer drug
Researchers at the Moores Cancer Center at the University of California, San Diego (UC SD) in La Jolla have found evidence explaining why a common chemotherapy drug, cisplatin, may not always work for every cancer patient. They have shown that when a variant version of a key protein that normally causes cell death is active, patients may be resistant to the cancer-killing drug.
A new biomarker for early cancer detection? Research reveals that 'microRNA' may fit the bill
Scientists at Fred Hutchinson Cancer Research Center have discovered that microRNAs – molecular workhorses that regulate gene expression – are released by cancer cells and circulate in the blood, which gives them the potential to become a new class of biomarkers to detect cancer at its earliest stages. Muneesh Tewari, M.D., Ph.D., and colleagues describe their findings in the July 28 issue of the Proceedings of the National Academy of Sciences.
Molecular 'clock' could predict risk for developing breast cancer
A chemical reaction in genes that control breast cancer provides a molecular clock that could one day help researchers more accurately determine a woman’s risk for developing breast cancer and provide a new approach for treatment, UT Southwestern Medical Center researchers have found.
Glypican-3 gene function in regulating body size helps inform novel cancer treatments
In a leading study that has implications for the development of novel therapies for a number of breast, lung and ovarian cancers that have lost the expression of a gene called glypican-3 (GPC3), Sunnybrook researchers have discovered how the loss of the GPC3 gene induces overgrowth through certain growth factors such as Sonic Hedgehog which stimulate cancer growth.
New cancer gene found
Researchers at the OU Cancer Institute have identified a new gene that causes cancer. The ground-breaking research appears in Nature’s cancer journal Oncogene.
Much of the increased risk of death from smoking reduced within several years after quitting
Women who quit smoking significantly reduce their risk of death from coronary heart disease within 5 years and have about a 20 percent lower risk of death from smoking-related cancers within that time period, according to a study in the May 7 issue of JAMA.
Researchers identify new cell targets for preventing growth of breast and other tumors
Researchers at the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have discovered new targets for cancer treatment aimed at blocking a key step in tumor progression.

Oocyte-specific gene mutations cause premature ovarian failure

Related stories:

News discussion: